Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Some deals happening right now in the aftermarket
More excitement needs to be created.
This board has been quiet for a while, only to awaken recently with the FDA approval.
There have got to be many opinions as to the forword movement of the company and it's products, prospective partners, and ongoing trials.
Taking valid goosebump PT's
I don't think any of that is necessary.
The short percentage is low.
The company is preparing for a bombshell release (Think about the reason for the halt yesterday).
Get ready for goosebumps!
I stole a MEGA-BUNCH @1.91
The halt yesterday was interesting...
too interesting to pass up...
This will move when all the shorts decide to go long...very rigged and manipulated stock here. Dam pussies...lol
People talking about how the shorts and MM's are holding this down .... Well , I'm waiting for the Reddit crew to come in and crush them all the way to Hell !!! Let this pull a GME or a GLSI and you will hear them all screaming and crying how the market is being manipulated !!! The same way they cried a few months ago ... all of a sudden when they got hurt they ran to the SEC and Congress crying about needing market reform !!! Please , let the WSB's skyrocket this and burn the midgets real bad !!!!!!
Trading $2.60s pre market....what a joke. Has to rebound today...you would think
This is a POS.....Strong Buy Thats a joke.....Selling as soon as I can ....
Maybe if they get some bad news....this will turn around.....wtf ?
Picked up some $2.07 after hours
$2.01 so far. Unbelievable...
Right about now !
MMs really working on this one.....This should rebound really good...IMO
Smells like fish
Gap close $2.12-$2.29
$DARE: They halted it all day with $10 bids
CRIMINAL WHAT THEY DID.
GO $DARE
#DARE ?? FDA APPROVAL news!! Should we buy now? What is the price target and chart analysis?
sure wish i had got my 2.25 but sitting on sideline now
nice little pop,now whats it going do ?lol
Traders Circulate FDA AccessData.gov Listing Showing Dare's Clindamycin Phosphate Vaginal Gel FDA Approved
12/7/21, 12:29 PM
December 7, 2021 12:29 PM ET (BZ Newswire) -- Biotech
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215650
Halted for news. GL. I have no......
position, but have owned DARE from time to time.
HOW is an honest individual investor supposed to make any money?
What's that? That's not part of the game? Oh. Never mind.
Twitter trading blogs reporting two naked short hedge funds closing out short positions today, MM short criminals helping them out and themselves with out right corrupt manipulation to do it.
Keep shorting tards, the reddit crowd is coming for you and squeeze you criminals over two bucks today.
PH3 Topline presentation tomorrow...
The study met its primary endpoint and demonstrated that as a primary therapeutic intervention a single vaginal dose of DARE-BV1 achieved clinical cure rates of 70-81%.
Multiple PH3, multiple PH2, multiple early stages Trials. Huge grants coming in. The most recent was 70% of the current market cap. 40M shares and a
$70M market cap.
It currently sits at historic support.
$45 Million can give DARE a lot of runway to get some corporate development news out.
Running AH's, wonder why, but shorty is paying for it.
Bill & Melinda Gates Foundation gives Dare Bioscience a boost
Based on the 3 sell side analysts who offered a 12-month price target in the last three months. Analysts predict a(n) 300.63% increase from today.
Strong Buy is based on the overall consensus of 3 analysts who offered ratings over the last three months.
Bill & Melinda Gates Foundation gives Dare Bioscience a boost.
Dare Bioscience stock rockets after new $49 million grant from Bill & Melinda Gates Foundation.
Shares of Dare Bioscience Inc. DARE, -3.72% rocketed 63.1% in very active premarket trading Wednesday, after the California-based health care company said it was awarded a new grant of up to $48.95 million from the Bill & Melinda Gates Foundation. Trading volume spiked up to 18.1 million shares, compared with the full-day average of about 3.7 million shares. The new grant is to support the development and preclinical activities to advance Dare's investigational reversible contraceptive, DARE-LARC1, toward testing in humans. As part of the grant agreement, DARE agreed to make DARE-LARC1 and any other products available at an affordable price to people in developing countries, or in support of the U.S. educational system and public libraries. The stock has lost 10.6% over the past three months through Tuesday, while the iShares Nasdaq Biotechnology
Great news for a small biotech. To be found by the Gates Foundation is no small thing.
Followers
|
64
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1728
|
Created
|
08/15/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |